← ANALYSTS · TIPRANKS
Jason Zemansky · Bank of America Securities
Hits
60%
151 of 251 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+21.6%
Over a year after the rating, TipRanks’ measure
Our companies rated now
17
Buy / hold / sell: 11 / 5 / 1
Upside of the analyst’s targets
+129.0%
Average over 17 current targets, to the last price
The market’s answer to the ratings
+7.7%
Day-0 move against SPY in the rating’s direction, average over 4 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 14on TipRanks 06:45 | KURAIWMKura Oncology · $863M | Reiterated | Buy | $31.00 | +241.4% | −1.2%next day +0.7% | ↗ |
| Oct 13on TipRanks 06:26 | SNDXIWMSyndax Pharmaceuticals · $1.2B | Reiterated | Buy | $26.00 → $23.00−11.5% | +78.3% | −15.7%next day −1.9% | ↗ |
| Oct 11on TipRanks Oct 12 06:50 | INSMInsmed · $21.5B | Reiterated | Buy | $207 | +115.0% | −2.0%next day −1.8% | ↗ |
| Oct 7on TipRanks 05:45 | RCKTIWMRocket Pharmaceuticals · $259M | Reiterated | Buy | $10.00 | +358.7% | +2.5%next day +4.2% · 5 days −11.8% | ↗ |
| Oct 6on TipRanks Oct 7 06:45 | BBIOBridgeBio Pharma · $12.4B | Reiterated | Buy | $104 | +56.7% | +0.7%next day −0.4% · 5 days −5.3% | ↗ |
| Oct 5on TipRanks 07:25 | RCUSIWMArcus Biosciences · $2.9B | Reiterated | Hold | $29.00 | +31.1% | +0.6%next day −2.4% · 5 days −2.0% | ↗ |
| Sep 29on TipRanks 12:09 | KURAIWMKura Oncology · $863M | Reiterated | Buy | $31.00 | +241.4% | +2.0%next day −0.7% · 5 days −4.5% | ↗ |
| Sep 28on TipRanks 06:25 | EIKNIWMEikon Therapeutics, Inc. · $408M | Reiterated | Buy | $32.00 | +331.3% | +0.6%next day +0.2% · 5 days −5.9% | ↗ |
| Sep 23on TipRanks Sep 24 05:25 | TVTXIWMTravere Therapeutics · $5.0B | Reiterated | Buy | $71.00 | +43.1% | 0.0%next day +1.4% · 5 days −0.9% | ↗ |
| Sep 22on TipRanks Sep 23 04:45 | LGNDIWMLigand Pharma · $6.0B | Reiterated | Buy | $388 | +31.3% | +2.9%next day +0.7% · 5 days +5.2% | ↗ |
| Sep 21on TipRanks Sep 22 06:15 | INSMInsmed · $21.5B | Reiterated | Buy | $214 | +122.3% | −0.7%next day −0.1% · 5 days −1.7% | ↗ |
| Sep 17on TipRanks 04:55 | ABOSIWMAcumen Pharmaceuticals · $126M | Reiterated | Buy | $8.00 | +373.4% | −2.7%next day +3.0% · 5 days −13.9% | ↗ |
| Sep 15on TipRanks Sep 16 04:55 | RCKTIWMRocket Pharmaceuticals · $259M | Reiterated | Buy | $10.00 | +358.7% | −0.1%next day +2.5% · 5 days −4.1% | ↗ |
| Sep 8on TipRanks 06:25 | TYRAIWMTyra Bioscience · $1.3B | Reiterated | Buy | $39.00 | +110.6% | −6.2%next day −17.2% · 5 days −3.7% | ↗ |
| Aug 31on TipRanks 06:35 | CYTKIWMCytokinetics · $8.9B | Reiterated | Hold | $85.00 | +37.2% | −1.3%next day +1.4% · 5 days +6.4% | ↗ |
| Aug 11on TipRanks 09:00 | KROSIWMKeros Therapeutics · $219M | Reiterated | Hold | $20.00 → $17.00−15.0% | +59.5% | −0.1%next day +5.0% · 5 days +0.1% | ↗ |
| Aug 11on TipRanks 08:50 | RCUSIWMArcus Biosciences · $2.9B | Reiterated | Hold | $29.00 | +31.1% | +0.4%next day +0.5% · 5 days +3.1% | ↗ |
| Aug 11on TipRanks 08:50 | LYELIWMLyell Immunopharma · $196M | Reiterated | Sell | $12.00 | +47.8% | +4.2%next day −5.0% · 5 days +6.5% | ↗ |
| Aug 11on TipRanks 04:55 | BBIOBridgeBio Pharma · $12.4B | Reiterated | Buy | $104 | +56.7% | −0.8%next day −0.1% · 5 days −0.5% | ↗ |
| Aug 5on TipRanks 07:51 | SNDXIWMSyndax Pharmaceuticals · $1.2B | Reiterated | Buy | $26.00 | +101.6% | +4.6%next day −0.6% · 5 days −1.0% | ↗ |
| Jul 30on TipRanks Jul 31 06:05 | MDGLMadrigal Pharmaceuticals · $10.4B | Reiterated | Hold | $553 → $543−1.8% | +20.7% | −11.5%next day −6.0% · 5 days −0.1% | ↗ |
| Jul 29on TipRanks 08:20 | BIIBSPYBiogen · $34.8B | Reiterated | Hold | $215 → $219+1.9% | −5.9% | +3.3%next day −2.3% · 5 days −6.8% | ↗ |
| Jul 27on TipRanks Jul 28 06:50 | IKTIWMInhibikase Therapeutics · $255M | Reiterated | Buy | $6.00 | +263.6% | +0.8%next day −1.9% · 5 days −8.5% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗